taxonomy (1)
protein (2)
source (2)
structure (0)
composition (17)
disease (1)
reference (2)
site (2)
peptide (1)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
Reported structure
- HexNAc:1 (avg mass : 221.2103 )
- Hex:3 HexNAc:3 (avg mass : 1114.0275 )
- Hex:3 HexNAc:3 dHex:1 (avg mass : 1260.1705 )
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:3 HexNAc:5 (avg mass : 1520.4175 )
- Hex:4 HexNAc:3 dHex:1 (avg mass : 1422.3129 )
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1713.5708 )
- Hex:4 HexNAc:4 (avg mass : 1479.3649 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:5 (avg mass : 1682.5599 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:3 (avg mass : 1438.3123 )
- Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:6 HexNAc:3 (avg mass : 1600.4547 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
Composition
- COVID-19 (DOID:0080600)
Disease
- Site-specific analysis of the SARS-CoV-2 glycan shield (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
Reference
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
Mass spectrometry observed peptide
-
- HexNAc:1 / N-Linked (avg mass : 221.2103)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
-
- Hex:3 HexNAc:3 / N-Linked (avg mass : 1114.0275)
- FreeStyle 293-F (CVCL_D603)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
-
- Hex:5 HexNAc:2 / N-Linked (avg mass : 1235.1173)
- COVID-19 (DOID:0080600)
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Unreviewed
- Site-specific analysis of the SARS-CoV-2 glycan shield (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
-
- Hex:3 HexNAc:3 dHex:1 / N-Linked (avg mass : 1260.1705)
- FreeStyle 293-F (CVCL_D603)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
-
- Hex:4 HexNAc:3 dHex:1 / N-Linked (avg mass : 1422.3129)
- FreeStyle 293-F (CVCL_D603)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
-
- Hex:5 HexNAc:3 / N-Linked (avg mass : 1438.3123)
- FreeStyle 293-F (CVCL_D603)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
-
- Hex:3 HexNAc:4 dHex:1 / N-Linked (avg mass : 1463.3655)
- FreeStyle 293-F (CVCL_D603)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
-
- Hex:4 HexNAc:4 / N-Linked (avg mass : 1479.3649)
- FreeStyle 293-F (CVCL_D603)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
-
- Hex:3 HexNAc:5 / N-Linked (avg mass : 1520.4175)
- FreeStyle 293-F (CVCL_D603)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
-
- Hex:7 HexNAc:2 / N-Linked (avg mass : 1559.4021)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (HEK293) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
-
- Hex:6 HexNAc:3 / N-Linked (avg mass : 1600.4547)
- FreeStyle 293-F (CVCL_D603)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
-
- Hex:4 HexNAc:4 dHex:1 / N-Linked (avg mass : 1625.5079)
- FreeStyle 293-F (CVCL_D603)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
-
- Hex:4 HexNAc:5 / N-Linked (avg mass : 1682.5599)
- FreeStyle 293-F (CVCL_D603)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
-
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 / N-Linked (avg mass : 1713.5708)
- FreeStyle 293-F (CVCL_D603)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
-
- Hex:5 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1729.5702)
- FreeStyle 293-F (CVCL_D603)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
-
- Hex:5 HexNAc:4 dHex:1 / N-Linked (avg mass : 1787.6503)
- FreeStyle 293-F (CVCL_D603)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- FreeStyle 293-F (CVCL_D603)
- COVID-19 (DOID:0080600)
- Recombinant Spike glycoprotein (FreeStyle 293-F) - DRAFT DATA / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- IVNNATNVVIKVCEF (15aa)
- IVNNATNVVIKVCEF (15aa)
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
